A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which remains in research studies, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles privately for supplier links, while also obtaining promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where communities with thousands of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Professionals Express Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users injecting substances of unknown origin.
Some professionals stated the demand for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach medicines, marketing, and consumer regulations, risking penalties, legal action or prison.
Platform Reaction and Material Removal
According to the social media company, the service has removed problematic material and banned related keywords and query recommendations. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of entering one group, a vendor posted WhatsApp details, where most transactions take place. The vendor provided an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or previous experience.
Product Details and Costs
Within these communities, messages show dark colored packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they cannot confirm. Even if the research behind this drug is sound, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has previously seen patients harmed by personal administration from unverified suppliers. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Manufacturer Statement
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to potentially significant health risks”.
